A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT07599423 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07599423
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-22
- Primary completion
- 2030-07-21
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.